Showing 1–12 of 16 results

Show sidebar

CABOZANIX 80 MG

Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and

LAPANIX 250 MG

LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase

LUCIBRU 140 MG

LUCIBRU Ibrutinib capsules 140mg 120 capsules Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton’s

OBETIX 5 MG

DESCRIPTION Product Description: Obetix is the only choice for Primary Biliary Cirrhosis (PBC) with the combination of UDCA (Ursodeoxycholic Acid)

OLANIB 150 MG

DESCRIPTION Olanib (Olaparib) Olanib is used for the returning treatment of some types of ovarian cancer in patients who have

OSICENT 80 MG

DESCRIPTION Indications Osimertinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small

PALBONIX 125 MG

DESCRIPTION Product Description: Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:

REGONIX 40 MG

Product Description: Regorafenib is an oral multi-kinase inhibitor involved in normal cellular functioning and in pathological processes such as oncogenesis,

SUNITIX 25 MG

 Sunitix Capsule Sunitinib 25 mg Beacon Pharmaceuticals Ltd.  Indications Gastrointestinal Stromal Tumor (GIST): Sunitinib is indicated for the treatment of gastrointestinal